Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders Equity

v3.25.4
Consolidated Statements of Stockholders Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (loss)
Balance, shares at Dec. 31, 2023   552      
Balance, amount at Dec. 31, 2023 $ 11,752 $ 1 $ 52,264 $ (40,310) $ (203)
Common stock issued for cash, net of issuance costs, shares   15      
Common stock issued for cash, net of issuance costs, amount 112 $ 0 112 0 0
Stock based compensation 818 0 818 0 0
Net loss for the period (9,826) 0 0 (9,826) 0
Other comprehensive loss 1 $ 0 0 0 1
Balance, shares at Dec. 31, 2024   567      
Balance, amount at Dec. 31, 2024 2,857 $ 1 53,194 (50,136) (202)
Common stock issued for cash, net of issuance costs, shares   1,329      
Common stock issued for cash, net of issuance costs, amount 6,151 $ 1 6,150 0 0
Stock based compensation 1,142 0 1,142 0 0
Net loss for the period (12,879) 0 0 (12,879) 0
Other comprehensive loss (70) $ 0 0 0 (70)
Warrants exercised, shares   123      
Warrants exercised, amount 132 $ 0 132 0 0
Fair value of warrants issued upon extinguishment of debt 1,395 $ 0 1,395 0 0
Balance, shares at Dec. 31, 2025   2,019      
Balance, amount at Dec. 31, 2025 $ (1,272) $ 2 $ 62,013 $ (63,015) $ (272)